Richard D. Gelber
Harvard University
2 papers in the Anchorcite directory, published between 1994 and 2005, cited 8,884 times in total.
ORCID profileResearch topics
- Monoclonal and Polyclonal Antibodies Research · 1 paper
- HER2/EGFR in Cancer Research · 1 paper
- Breast Cancer Treatment Studies · 1 paper
- HIV Research and Treatment · 1 paper
- HIV/AIDS drug development and treatment · 1 paper
- HIV/AIDS Research and Interventions · 1 paper
Frequent co-authors
- Martine J Piccart · 1 paper
- Marion Jennifer Procter · 1 paper
- Brian R Leyland-Jones · 1 paper
- Aron Goldhirsch · 1 paper
- Michael Untch · 1 paper
- Ian Smith · 1 paper
- Luca Gianni · 1 paper
- José Baselga · 1 paper
Papers
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine · 2005 · 5,137 citations
BACKGROUND: Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in advanced breast cancer that overexpresses HER2. We investigated its efficacy and safety after excision of early-stage breast cancer and completion of chemotherapy. METHODS: This international, multicenter, randomized trial…
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine · 1994 · 3,747 citations
BACKGROUND AND METHODS: Maternal-infant transmission is the primary means by which young children become infected with human immunodeficiency virus type 1 (HIV). We conducted a randomized, double-blind, placebo-controlled trial of the efficacy and safety of zidovudine in reducing the risk…
Metadata from OpenAlex (CC0).